Tech Daily Utah
SEE OTHER BRANDS

Fresh news on science and technology in Utah

Tech Daily Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.

Press releases published on June 10, 2025

Sally Launch Features the First Fully Automated, White-Labeled SPV Platform

Sally Launch Features the First Fully Automated, White-Labeled SPV Platform

Trailblazing software platform empowers investors across the spectrum with unprecedented control over the investor experience and brand SALT LAKE CITY, UT, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Built for Modern Dealmakers Today marks the …

Gulf View Medical Centre in Trinidad Marks Four Years of Digital Transformation With Adroit’s eHospital Systems

Gulf View Medical Centre in Trinidad Marks Four Years of Digital Transformation With Adroit’s eHospital Systems

Gulf View Medical Centre celebrates 4 years using Adroit’s eHospital Systems to drive digital care, patient access, and operational efficiency. SOUTH JORDAN, UT, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- Gulf View Medical Centre, one of the …

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech

EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and improved functional outcomes in patients …

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus…

Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to low double-digit royalties on Global Net Sales OTELFINGEN, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- …

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

NORTH BRUNSWICK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for acute and chronic inflammatory diseases, announces that it will conduct a Phase 2 study of rhu-pGSN …

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced it will …

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

WALTHAM, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the …

Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024

Micropolis Holding Company Filed Annual Report on Form 20-F for the Year Ended December 31, 2024

DUBAI, United Arab Emirates, June 10, 2025 (GLOBE NEWSWIRE) -- Micropolis Holding Company (“Micropolis” or the “Company”) (NYSE American: MCRP), a pioneer in unmanned ground vehicles and AI-driven security solutions, announced today that it has filed its …

CEA Industries to Participate at the Sidoti Conference on June 12, 2025

CEA Industries to Participate at the Sidoti Conference on June 12, 2025

Louisville, Colorado, June 10, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), today announced its participation at the upcoming Sidoti Conference being held virtually June 11-12, 2025. CEA Industries …

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under  Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on June 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 74 …

Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors

Vimeo Elects Adam Cahan, Lydia Jett, and Kirsten Kliphouse to Board of Directors

NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Vimeo, Inc. (NASDAQ: VMEO), one of the largest and most trusted private video networks in the world, today announced the election of Adam Cahan, Lydia Jett, and Kirsten Kliphouse to its Board of Directors. The …

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 10, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 10 juin 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …

Celularity Announces Chief Financial Officer Transition

Celularity Announces Chief Financial Officer Transition

FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), …

 HP Inc. Declares Dividend

HP Inc. Declares Dividend

PALO ALTO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) has declared a cash dividend of $0.2894 per share on the company’s common stock. The dividend, the fourth in HP’s fiscal year 2025, is payable on October 1, 2025, to stockholders of …

Quick Custom Intelligence Continues Rapid Growth in the Australian Market in Partnership with Gaming Dynamics

Quick Custom Intelligence Continues Rapid Growth in the Australian Market in Partnership with Gaming Dynamics

SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in operational intelligence software for the gaming and hospitality industries, is pleased to announce continued expansion across Australia in collaboration with …

Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price

Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price

NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness …

New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments

New Spherix Global Insights Data Reveals 85% of FSGS Patients Have Actively Progressing Disease Despite Treatment, Underscoring Urgent Demand for Innovative Treatments

EXTON, PA, June 10, 2025 (GLOBE NEWSWIRE) -- Patients battling focal segmental glomerulosclerosis (FSGS) often face a discouraging path, marked by continued disease progression and limited therapeutic options. For nephrologists, this rare kidney disease is …

Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress

Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress

HAMPTON, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that data from the Company’s Phase 2 study of barzolvolimab in chronic spontaneous urticaria will be presented at the EAACI Congress 2025 being held in Glasgow, Scotland …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service